Literature DB >> 9426035

Circadian rhythms of atrioventricular conduction properties in chronic atrial fibrillation with and without heart failure.

J Hayano1, S Sakata, A Okada, S Mukai, T Fujinami.   

Abstract

OBJECTIVES: We examined the circadian variations in atrioventricular (AV) conduction properties during atrial fibrillation (AF) by a technique based on the Lorenz plot of successive ventricular response (VR) intervals and analyzed their relations with clinical features.
BACKGROUND: The VR interval in chronic AF shows circadian variation, which is attenuated in patients with an increased risk of death. Although the VR interval is determined by the dynamic processes in the AV node randomly stimulated by rapid atrial activity, the circadian variations of the AV conduction properties related to this mechanism are unknown.
METHODS: In 48 patients with chronic AF, Lorenz plots were generated on overlapping sequential segments of 512 VR intervals in 24-h ambulatory electrocardiograms. For each scatter plot, the 1.0-s intercept of the lower envelope (LE1.0) of the plot and the degree of scatter above the envelope (root mean square difference from the envelope [scattering index]) were measured for estimating AV node refractoriness and concealed AV conduction, respectively.
RESULTS: In all patients, a significant circadian rhythm was observed for the average VR interval, LE1.0 and scattering index, with an acrophase occurring at night. The mesor, amplitude and acrophase of LE1.0 and the scattering index closely and independently correlated with the corresponding rhythm variables of the average VR interval (partial r2 0.98, 0.86 and 0.68 for LE1.0 and 0.98, 0.92 and 0.92 for scattering index). The amplitudes of these measures were lower in patients with congestive heart failure (CHF) even after adjustment for the effects of age, duration of AF, medications, left atrial diameter and blood pressure (p < 0.01 for all).
CONCLUSIONS: These results suggest that 1) both AV node refractoriness and the degree of concealed AV conduction during AF may show a circadian rhythm; 2) the circadian rhythms of these properties may independently contribute to the circadian variation of the VR interval; and 3) these circadian rhythms may be attenuated in patients with CHF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9426035     DOI: 10.1016/s0735-1097(97)00429-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  11 in total

Review 1.  Complexities in cardiovascular rhythmicity: perspectives on circadian normality, ageing and disease.

Authors:  Oliver Monfredi; Edward G Lakatta
Journal:  Cardiovasc Res       Date:  2019-09-01       Impact factor: 10.787

2.  Noninvasive Assessment of Atrioventricular Nodal Function: Effect of Rate-Control Drugs during Atrial Fibrillation.

Authors:  Valentina D A Corino; Frida Sandberg; Luca T Mainardi; Pyotr G Platonov; Leif Sörnmo
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-12-26       Impact factor: 1.468

3.  Atrioventricular conduction properties in patients with prolonged pauses undergoing ablation of longstanding persistent atrial fibrillation: do pauses during atrial fibrillation matter?

Authors:  Akinori Sairaku; Yukiko Nakano; Noboru Oda; Yuko Makita; Kenta Kajihara; Takehito Tokuyama; Chikaaki Motoda; Mai Fujiwara; Yasuki Kihara
Journal:  J Interv Card Electrophysiol       Date:  2012-02-23       Impact factor: 1.900

Review 4.  Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.

Authors:  Giuseppe Boriani; Mauro Biffi; Igor Diemberger; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Reduced diurnal variation of heart rate is associated with increased plasma B-type natriuretic peptide level in patients with atrial fibrillation.

Authors:  Shigeshi Kamikawa; Toru Miyoshi; Masayuki Doi; Naoko Orita; Mutsuko Sangawa; Takaaki Nakatsu; Youko Noguchi; Satoshi Hirohata; Shozo Kusachi; Kazufumi Nakamura; Hiroshi Ito
Journal:  Clin Cardiol       Date:  2013-04-12       Impact factor: 2.882

6.  Electrophysiological characteristics associated with symptoms in pacemaker patients with paroxysmal atrial fibrillation.

Authors:  John Silberbauer; Rick A Veasey; Elizabeth Cheek; Nadeem Maddekar; Neil Sulke
Journal:  J Interv Card Electrophysiol       Date:  2009-07-28       Impact factor: 1.900

7.  Circadian variation in ventricular tachycardia and atrial fibrillation in a medical-cardiological ICU.

Authors:  Georg Delle Karth; Peter Reinelt; Anton Buberl; Alexander Geppert; Martin Huelsmann; Rudolf Berger; Gottfried Heinz
Journal:  Intensive Care Med       Date:  2003-04-16       Impact factor: 17.440

8.  Relationship between HRV measurements and demographic and clinical variables in a population of patients with atrial fibrillation.

Authors:  Carmelo Buttà; Antonino Tuttolomondo; Alessandra Casuccio; Rossella Petrantoni; Giuseppe Miceli; Francesco Cuttitta; Antonio Pinto
Journal:  Heart Vessels       Date:  2016-03-03       Impact factor: 2.037

9.  The effect of head-up tilt upon markers of heart rate variability in patients with atrial fibrillation.

Authors:  Hitesh C Patel; Carl Hayward; Andrew J Wardle; Lee Middleton; Alexander R Lyon; Carlo Di Mario; Tushar V Salukhe; Richard Sutton; Stuart D Rosen
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-10-15       Impact factor: 1.468

10.  Multiscale Entropy of the Heart Rate Variability for the Prediction of an Ischemic Stroke in Patients with Permanent Atrial Fibrillation.

Authors:  Eiichi Watanabe; Ken Kiyono; Junichiro Hayano; Yoshiharu Yamamoto; Joji Inamasu; Mayumi Yamamoto; Tomohide Ichikawa; Yoshihiro Sobue; Masehide Harada; Yukio Ozaki
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.